Evidence map›Paper›PMID 30651587›Full record

Trial reportBone marrow transplantation2019

Tyrosine kinase inhibitor levels matter in treating chronic GVHD.

Lotte van der Wagen, Julie Janssen, Reinier Raijmakers, Eefke Petersen, Moniek de Witte, Niels de Jong, Mar Bellido, Ellen Meijer, Brigitte Bär, Jaap Jan Boelens and 2 more

Open access · bronzeAbstract readClinical Trial, Phase IILetterMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Lotte van der WagenDepartment of Hematology, University Medical Center Utrecht, Room number Q05.4.301, PO Box 85500, Utrecht, GA, 3508, The Netherlands.
Julie JanssenDepartment of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Reinier RaijmakersDepartment of Hematology, University Medical Center Utrecht, Room number Q05.4.301, PO Box 85500, Utrecht, GA, 3508, The Netherlands.
Eefke PetersenDepartment of Hematology, University Medical Center Utrecht, Room number Q05.4.301, PO Box 85500, Utrecht, GA, 3508, The Netherlands.
Moniek de WitteDepartment of Hematology, University Medical Center Utrecht, Room number Q05.4.301, PO Box 85500, Utrecht, GA, 3508, The Netherlands.
Niels de JongDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-2054-0752
Mar BellidoDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Ellen MeijerDepartment of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Brigitte BärDepartment of Hematology, Radboud Medical Center, Nijmegen, The Netherlands.
Jaap Jan BoelensLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Alwin HuitemaDepartment of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Jürgen KuballDepartment of Hematology, University Medical Center Utrecht, Room number Q05.4.301, PO Box 85500, Utrecht, GA, 3508, The Netherlands. j.h.e.kuball@umcutrecht.nl.
Utrecht University · NLThe Netherlands Cancer Institute · NLAmsterdam University Medical Centers · NLErasmus MC · NLMemorial Sloan Kettering Cancer Center · USRadboud University Nijmegen · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RegistriesStem Cell TransplantationAllograftsChronic DiseaseFemaleGraft vs Host DiseaseHumansMaleNetherlandsProspective StudiesProtein Kinase InhibitorsPyrimidinesRetrospective StudiesRituximabnilotinibProtein Kinase InhibitorsPyrimidinesRituximab

Identifiers

PMID30651587
OpenAlexW2910352776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.